Events

17 April 2012 / Ørestad / Denmark Medicon Valley Alliance in cooperation with DNB invites you to participate in a network meeting on how to attract investors and industry partners to a life science company. At the meeting you will also have the opportunity to present you technology / business plan to any of the […]

Hear about MVA and our networks and initiatives. Get an insight into what value your organization gains from your membership of MVA.  Learn more about how MVA works to maintain and develop the attractiveness of Medicon Valley. 22 March 2012 / Ørestad / Denmark Join other members and non-members at the introductory meeting to MVA […]

This seminar will address several of todays key challenges in drug development leading up to clinical proof of concept. The agenda brings together a panel of speakers from academia, pharmaceutical companies and solution providers to discuss key issues from formulation design right through to effective clinical trial planning. The final session w ill discuss how […]

Organotypic 3D-cell-culture systems are implemented at various stages in the compound development process for de-risking new drug candidates and can provide a wealth of meaningful efficacy and toxicology data. A growing list of publications confirms the striking similarities of these systems to in vivo tissue, clearly underlining their high potential value to the pharmaceutical industry. […]